IRIS UniCatt

Pierconti, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.162
EU - Europa 4.111
AS - Asia 3.917
SA - Sud America 783
AF - Africa 115
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 9
AN - Antartide 1
Totale 14.110
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.008
SG - Singapore 1.728
IT - Italia 1.204
CN - Cina 867
DE - Germania 696
SE - Svezia 679
BR - Brasile 641
VN - Vietnam 401
FR - Francia 317
PL - Polonia 310
IN - India 182
UA - Ucraina 179
GB - Regno Unito 163
IE - Irlanda 149
BD - Bangladesh 130
ID - Indonesia 120
JP - Giappone 117
FI - Finlandia 92
RU - Federazione Russa 79
CA - Canada 77
NL - Olanda 73
HK - Hong Kong 70
TR - Turchia 63
AR - Argentina 51
MX - Messico 41
BE - Belgio 35
IQ - Iraq 35
ZA - Sudafrica 32
ES - Italia 30
KR - Corea 27
AT - Austria 26
EC - Ecuador 23
PK - Pakistan 21
CI - Costa d'Avorio 18
CO - Colombia 18
IR - Iran 17
MA - Marocco 17
UZ - Uzbekistan 16
VE - Venezuela 16
JO - Giordania 14
SA - Arabia Saudita 14
CH - Svizzera 13
LT - Lituania 11
AZ - Azerbaigian 10
PH - Filippine 10
AE - Emirati Arabi Uniti 9
CR - Costa Rica 9
NP - Nepal 9
PE - Perù 9
PY - Paraguay 9
AU - Australia 8
KE - Kenya 8
OM - Oman 8
UY - Uruguay 8
DZ - Algeria 7
EG - Egitto 7
LV - Lettonia 7
CL - Cile 6
JM - Giamaica 6
LB - Libano 6
NO - Norvegia 6
TN - Tunisia 6
ET - Etiopia 5
LK - Sri Lanka 5
NI - Nicaragua 5
SN - Senegal 5
TT - Trinidad e Tobago 5
AL - Albania 4
BG - Bulgaria 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GR - Grecia 4
IL - Israele 4
KZ - Kazakistan 4
MD - Moldavia 4
MY - Malesia 4
PT - Portogallo 4
RO - Romania 4
CZ - Repubblica Ceca 3
EU - Europa 3
HR - Croazia 3
KG - Kirghizistan 3
KW - Kuwait 3
MM - Myanmar 3
NG - Nigeria 3
PA - Panama 3
PS - Palestinian Territory 3
A1 - Anonimo 2
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
GE - Georgia 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
TH - Thailandia 2
TJ - Tagikistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
Totale 14.089
Salva come PNG Salva come JPEG
Città #
Singapore 986
Chandler 571
Ashburn 562
San Jose 488
Warsaw 289
Beijing 185
Ho Chi Minh City 154
Milan 152
Dublin 149
Rome 149
Los Angeles 139
New York 138
Ann Arbor 127
Fairfield 117
San Mateo 112
The Dalles 112
Wilmington 105
Jacksonville 104
Lauterbourg 103
Jakarta 102
Hanoi 96
Nanjing 94
Seattle 94
Frankfurt am Main 90
Tokyo 82
Chicago 79
Houston 77
Cambridge 69
Woodbridge 66
São Paulo 65
Munich 64
Hefei 62
Hong Kong 62
Dearborn 59
Boston 58
Hyderabad 58
Moscow 58
Princeton 52
Council Bluffs 48
Santa Clara 45
Helsinki 43
Redmond 43
Izmir 42
Dallas 41
Bremen 40
Nanchang 36
Marseille 34
Orem 34
Cattolica 31
Stockholm 31
Bologna 29
Brussels 29
Kadoma 28
Lawrence 28
Verona 28
Buffalo 27
Naples 27
Montreal 24
Nürnberg 24
Seoul 24
Shanghai 24
Bari 22
Denver 22
Florence 22
Belo Horizonte 21
Johannesburg 21
Kent 21
London 21
Redwood City 21
Toronto 21
Shenyang 19
Abidjan 18
Atlanta 18
Da Nang 18
Enterprise 18
Mountain View 18
Amsterdam 17
Brasília 17
Düsseldorf 17
Kunming 17
Nuremberg 17
Palermo 17
Boardman 16
Brooklyn 16
Catania 16
Chennai 16
Hangzhou 16
Manchester 16
Paris 16
Tianjin 16
Vienna 16
Dhaka 15
Guangzhou 15
Mumbai 15
Baghdad 14
Phoenix 14
Rio de Janeiro 14
Tashkent 14
Turin 14
Amman 13
Totale 7.564
Salva come PNG Salva come JPEG
Nome #
Ruolo della risonanza magnetica funzionale (DCE-MRI, DWI-MRI)in pazienti sottoposti a saturation biopsy per persistente sospetto di carcinoma prostatico nonostante un primo set bioptico negativo: risultati preliminari su esperienza monocentrica 920
MALAT1 and HOTAIR long non-coding RNAs play opposite role in estrogen-mediated transcriptional regulation in prostate cancer cells 420
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 322
H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer. 276
Metabolic reprogramming by malat1 depletion in prostate cancer 257
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 255
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 237
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 210
Incidental finding of right renal venous aneurysm in a patient with symptomatic ipsilateral renal carcinoma: a case report 191
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 185
MECKEL'S DIVERTICULUM FINDINGS ON TC-99 RED BLOOD SCINTIGRAPHY IN A BLEEDING LEUKEMIC PATIENT CONFIRMED BY TC-99 PERTENECHTATE SCINTIGRAPHY 179
Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex 174
Primary hepatic leiomyosarcoma in a young male after Hodgkin s disease: diagnostic pitfalls and therapeutic challenge 173
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 172
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 170
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma 170
Bladder and prostate metastasis from small cell lung cancer: a rare entity 168
H19-Dependent Transcriptional Regulation of beta 3 and beta 4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer 163
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 162
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 162
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 151
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report 151
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets. 149
Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer 148
Transferrin receptor 2 is frequently and highly expressed in glioblastomas 148
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 145
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 140
HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3) 140
Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy 139
Methylation study of the Paris system for reporting urinary (TPS) categories 136
Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine 135
Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples 133
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 133
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 132
Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma 132
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 132
Hypochromatic large urothelial cells in urine cytology are indicative of high grade urothelial carcinoma. 131
PTTG1/ZEB1 Axis Regulates E-Cadherin Expression in Human Seminoma 130
Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study 130
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 129
Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancers 129
Bax mutations are an infrequent event in indolent lymphomas and in mantle cell lymphoma 129
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging-Hystopatology correlations 127
Olfactory receptors in semen and in the male tract: From proteome to proteins 125
Biomarkers of response to advanced prostate cancer therapy 125
SPTBN1 Mediates the Cytoplasmic Constraint of PTTG1, Impairing Its Oncogenic Activity in Human Seminoma 124
Robot-Assisted Radical Prostatectomy Performed with the Novel Surgical Robotic Platform Hugo™ RAS: Monocentric First Series of 132 Cases Reporting Surgical, and Early Functional and Oncological Outcomes at a Tertiary Referral Robotic Center 124
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma 124
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study. 124
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 123
Paraneoplastic Hyperinsulinism due to Renal Cell Carcinoma Treated With Robotic Nephrectomy 123
Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma 122
Comparison between cytospin and liquid-based cytology in urine specimens classified according to the Paris System for Reporting Urinary Cytology 122
Titanised Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-Out Single-Incision Technique: Minimum 12-Months Follow-Up Study 122
The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration 121
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 120
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging–Hystopatology correlations 115
Prevalence of bladder cancer in Costello syndrome: New insights to drive clinical decision-making 115
Robotic versus Open Pyeloplasty: Perioperative and Functional Outcomes 114
The Role of Bladder Epicheck Test In Follow-Up of Patients with Non-Muscle Invasive Bladder Cancer 110
Tuberculous nephritis accompanying neuromyelitis optica: causal or coincidental association? 110
p53 expression in cytology samples may represent a marker of early-stage cancer 109
Prognostic Impact of H19/Cell Adhesion Molecules Circuitry on Prostate Cancer Biopsy 109
Cytological and histological changes in the urothelium produced by electromotive drug administration (EMDA) and by the combination of intravescical hyperthermia and chemotherapy (thermochemotherapy) 109
SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System 109
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 108
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 107
Patient pad count is a poor measure of urinary incontinence compared with 48-h pad test: results of a large-scale multicentre study 107
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma 103
Giant spermatic cord liposarcoma 103
Pituitary-tumour-transforming-gene 1 expression in testicular cancer 103
Prevalence and Antimicrobial Resistance Patterns of Hospital Acquired Infections through the COVID-19 Pandemic: Real-Word Data from a Tertiary Urological Centre 101
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence? 101
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 100
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma 100
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging—Hystopatology correlations 100
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples. 99
Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas 99
Cytologic Diagnosis of Oncocytic Neoplasms of the Thyroid Gland: The Importance of the Clinical Scenario. 99
Male sling placement for post-prostatectomy incontinence can involve a lengthy learning curve: A multi-outcome assessment via cumulative sum failure analysis 98
Proteomics for the identification of biomarkers in testicular cancer–review 97
Programmed Cell Death Ligand 1 (PD-L1) Immunohistochemical Expression in Advanced Urothelial Bladder Carcinoma: An Updated Review with Clinical and Pathological Implications 97
A multi-surgeon learning curve analysis of overall and site-specific positive surgical margins after RARP and implications for training 96
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 95
Objectively improving appropriateness of absorbent products provision to patients with urinary incontinence: The DIAPPER study 93
Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma 92
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 91
Mesenchymal differentiation of glioblastoma stem cells 89
Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts 88
34BetaE12 and Alfa-Methylacyl Coenzyme A Racemase (AMACR) Antibodies Better Than p63 Antibody Distinguish Normal and Neoplastic Glands in Prostatic Tissue With Thermal Artifacts 88
Bladder cancer in the time of machine learning: Intelligent tools for diagnosis and management 87
mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy 86
Transferrin receptor 2 is frequently and highly expressed in glioblastomas 86
PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders 86
Unusual localization and clinical presentation of primary central nervous system extranodal marginal zone B-cell lymphoma: A case report 83
Purely Off-Clamp Partial Nephrectomy: Robotic Approach Better than Open Using a Pentafecta Outcome with Propensity Score Matching 82
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies with Aggressive Behavior 82
Establishing tumor cell lines from aggressive telomerase-positive chordomas of the skull base: Technical note 79
Regulation of PDE5 expression in normal prostate, benign prostatic hyperplasia, and adenocarcinoma 79
First-line ICIs in renal cell carcinoma 72
Totale 13.990
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.908
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.908
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022860 76 39 27 80 70 28 38 125 41 57 131 148
2022/20231.769 249 232 139 261 92 210 84 130 179 69 83 41
2023/20241.194 79 227 62 75 89 158 93 61 24 84 104 138
2024/20252.177 70 61 196 94 175 128 75 101 243 247 448 339
2025/20265.652 743 187 313 690 969 285 1.005 296 377 362 253 172
2026/20271 1 0 0 0 0 0 0 0 0 0 0 0
Totale 14.325